by Tara Parker-Pope
From the Well Blog
"Reports filed with the Internal Revenue Service and provided by the A.A.P. show that the academy has received contributions from several companies with ties to statins, including $433,000 from Merck, $835,250 from Abbott Laboratories’ Ross Product Division and $216,000 from the Bristol-Myers Squibb company Mead Johnson Nutritionals. The biggest statin maker, Pfizer, is not listed as a contributor. The A.A.P. reported a total of $81 million in revenue in 2007."
Click here to read full article at www.well.blogs.nytimes.com
Showing posts with label pharmaceuticals. Show all posts
Showing posts with label pharmaceuticals. Show all posts
Thursday, December 12, 2013
Wednesday, December 11, 2013
Ben Goldacre: What doctors don't know about the drugs they prescribe
When a new drug gets tested, the results of the trials should be published for the rest of the medical world -- except much of the time, negative or inconclusive findings go unreported, leaving doctors and researchers in the dark. In this impassioned talk, Ben Goldacre explains why these unreported instances of negative data are especially misleading and dangerous.
TEDTalks is a daily video podcast of the best talks and performances from the TED Conference, where the world's leading thinkers and doers give the talk of their lives in 18 minutes (or less). Look for talks on Technology, Entertainment and Design -- plus science, business, global issues, the arts and much more.
www.ted.com
Half of US clinical trials go unpublished
Results are reported more thoroughly in government database than in journals.
by Nicola Jones
03 December 2013
The results of clinical trials are going unpublished as much as half the time, and those that are published omit some key details, a study has found.
US law requires the results of medical research for drugs approved by the US Food and Drug Administration to be submitted to a database called ClinicalTrials.gov. Results, including adverse effects, have been made public there since 2008. Researchers who do not post results within a year of trial completion risk losing grants and can be fined as much as US$10,000 per day. But the database was never meant to replace journal publications, which often contain longer descriptions of methods and results and are the basis for big reviews of research on a given drug.
In an analysis of 600 trials picked at random from the database, Agnes Dechartres, an epidemiologist at Paris Descartes University, and her colleagues have now found that only 50% had made their way into print. “Non-publication is a crucial problem for all stakeholders, from patients to health policy-makers,” says Dechartres. For one thing, she says, failure to publish results in journals breeches the implied contract with patients who participated in the trials. “If results are not [fully] available, we can consider that research wasted,” she says.
Click here to for full article on www.nature.com
by Nicola Jones
03 December 2013
The results of clinical trials are going unpublished as much as half the time, and those that are published omit some key details, a study has found.
US law requires the results of medical research for drugs approved by the US Food and Drug Administration to be submitted to a database called ClinicalTrials.gov. Results, including adverse effects, have been made public there since 2008. Researchers who do not post results within a year of trial completion risk losing grants and can be fined as much as US$10,000 per day. But the database was never meant to replace journal publications, which often contain longer descriptions of methods and results and are the basis for big reviews of research on a given drug.
In an analysis of 600 trials picked at random from the database, Agnes Dechartres, an epidemiologist at Paris Descartes University, and her colleagues have now found that only 50% had made their way into print. “Non-publication is a crucial problem for all stakeholders, from patients to health policy-makers,” says Dechartres. For one thing, she says, failure to publish results in journals breeches the implied contract with patients who participated in the trials. “If results are not [fully] available, we can consider that research wasted,” she says.
Click here to for full article on www.nature.com
Monday, January 14, 2013
Prescription-Drug-Induced Violence Medicine's Best Kept Secret?
Data Based Medicine Americas Ltd. announces free online tool to show possible links between prescription drugs and violence.
Toronto, Canada (PRWEB) November 12, 2012by David Carmichael
RxISK.org, the first free independent website for researching and reporting prescription drug side effects, has added a Violence Zone to demonstrate and collect data on the links between prescription drugs and violent thoughts and behavior — from mild to suicidal or homicidal.
This article first appeared on http://www.prweb.com, click here for full article.
Tuesday, October 9, 2012
Attention Disorder or Not, Pills to Help in School
By ALAN SCHWARZ
Published: October 9, 2012
CANTON, Ga. — When Dr. Michael Anderson hears about his low-income patients struggling in elementary school, he usually gives them a taste of some powerful medicine: Adderall.
The pills boost focus and impulse control in children with attention deficit hyperactivity disorder. Although A.D.H.D is the diagnosis Dr. Anderson makes, he calls the disorder “made up” and “an excuse” to prescribe the pills to treat what he considers the children’s true ill — poor academic performance in inadequate schools.
“I don’t have a whole lot of choice,” said Dr. Anderson, a pediatrician for many poor families in Cherokee County, north of Atlanta. “We’ve decided as a society that it’s too expensive to modify the kid’s environment. So we have to modify the kid.”
click to continue reading
Friday, May 11, 2012
No Exit?
We learned last year from a National Health and Nutrition Examination Survey that more than 10% of Americans are taking anti-depressants. This data would not be difficult to swallow if these drugs were proven to be effective and are prescribed responsibly by heath care practitioners, but they are not. Instead it is widely known that anti-depressants are not effective for mild to moderate depression.
Subscribe to:
Posts (Atom)